CNC - Centene Corp Stock Price, Fair Value and News

75.78USD-0.12 (-0.16%)Delayed as of 08 May 2024, 03:00 pm ET

Market Summary

USD75.78-0.12

Delayedas of 08 May 2024, 03:00 pm

-0.16%

CNC Stock Price

View Fullscreen

CNC RSI Chart

CNC Valuation

Market Cap

40.5B

Price/Earnings (Trailing)

14.81

Price/Sales (Trailing)

0.26

EV/EBITDA

7.42

Price/Free Cashflow

15.56

CNC Price/Sales (Trailing)

CNC Profitability

EBT Margin

2.37%

Return on Equity

10.11%

Return on Assets

3.31%

Free Cashflow Yield

6.43%

CNC Fundamentals

CNC Revenue

Revenue (TTM)

155.5B

Rev. Growth (Yr)

3.9%

Rev. Growth (Qtr)

2.4%

CNC Earnings

Earnings (TTM)

2.7B

Earnings Growth (Yr)

2.92%

Earnings Growth (Qtr)

2.5K%

Breaking Down CNC Revenue

52 Week Range

60.8376.43

(Low)(High)

Last 7 days

3.9%

Last 30 days

4.3%

Last 90 days

1.3%

Trailing 12 Months

11.2%

How does CNC drawdown profile look like?

CNC Financial Health

Current Ratio

1.17

Debt/Equity

0.66

Debt/Cashflow

0.19

CNC Investor Care

Buy Backs (1Y)

2.75%

Diluted EPS (TTM)

5.06

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	155.5B	0	0	0
2023	146.3B	147.9B	150.1B	154.0B
2022	133.2B	138.1B	141.6B	144.5B
2021	115.1B	118.4B	121.7B	126.0B
2020	82.2B	91.6B	101.7B	111.1B
2019	65.4B	69.5B	72.3B	74.6B
2018	49.9B	52.1B	56.4B	60.1B
2017	45.4B	46.4B	47.5B	48.4B
2016	24.6B	30.0B	35.0B	40.6B
2015	18.2B	19.7B	21.2B	22.8B
2014	11.8B	13.2B	14.8B	16.6B
2013	9.1B	9.7B	10.2B	10.9B
2012	5.7B	6.3B	7.3B	8.1B
2011	4.6B	4.8B	5.0B	5.3B
2010	4.2B	4.3B	4.4B	4.4B
2009	0	3.6B	3.9B	4.1B
2008	0	0	0	3.4B

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of Centene Corp

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Apr 26, 2024	asher andrew lynn	sold (taxes)	-351,004	75.68	-4,638	chief financial officer
Apr 01, 2024	casso katie	sold (taxes)	-72,358	78.48	-922	corporate controller & cao
Mar 31, 2024	eppinger frederick h	acquired	-	-	323	-
Mar 31, 2024	samuels theodore r. ii	acquired	-	-	323	-
Mar 31, 2024	deveydt wayne s	acquired	-	-	420	-
Mar 31, 2024	coughlin christopher j	acquired	-	-	388	-
Mar 31, 2024	burdick kenneth a	acquired	-	-	388	-
Mar 15, 2024	fasola kenneth j	sold (taxes)	-473,944	76.05	-6,232	president
Mar 15, 2024	koster christopher	sold (taxes)	-162,367	76.05	-2,135	secretary & general counsel
Mar 15, 2024	casso katie	sold (taxes)	-117,041	76.05	-1,539	corporate controller & cao

Which funds bought or sold CNC recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 06, 2024	Canoe Financial LP	added	378	1,409,780	31,537,700	0.54%
May 06, 2024	Hilltop National Bank	new	-	7,063	7,063	-%
May 06, 2024	ORG Partners LLC	unchanged	-	4,248	93,300	0.18%
May 06, 2024	Sciencast Management LP	new	-	885,568	885,568	0.54%
May 06, 2024	Empirical Finance, LLC	added	3.32	132,859	1,566,220	0.10%
May 06, 2024	Merit Financial Group, LLC	new	-	205,428	205,428	-%
May 06, 2024	IFG Advisory, LLC	sold off	-100	-201,852	-	-%
May 06, 2024	LSV ASSET MANAGEMENT	added	0.27	10,002,000	175,587,000	0.36%
May 06, 2024	Savant Capital, LLC	added	423	2,688,410	3,280,390	0.04%
May 06, 2024	Metis Global Partners, LLC	added	19.19	338,357	1,637,330	0.06%

Are Funds Buying or Selling CNC?

Are funds buying CNC calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own CNC

No. of Funds

Unveiling Centene Corp's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 13, 2024	vanguard group inc	11.45%	61,190,588	SC 13G/A
Feb 09, 2024	capital world investors	5.5%	29,150,898	SC 13G/A
Feb 09, 2024	fmr llc	-	0	SC 13G/A
Jan 26, 2024	blackrock inc.	7.6%	40,819,347	SC 13G/A
Feb 13, 2023	capital world investors	8.8%	49,809,061	SC 13G/A
Feb 09, 2023	fmr llc	-	0	SC 13G/A
Feb 09, 2023	vanguard group inc	11.52%	65,260,984	SC 13G/A
Jan 31, 2023	blackrock inc.	7.2%	40,669,044	SC 13G/A
Feb 14, 2022	price t rowe associates inc /md/	4.9%	28,709,382	SC 13G/A
Feb 11, 2022	capital world investors	8.0%	46,851,859	SC 13G/A

Recent SEC filings of Centene Corp

View All Filings

Date Filed	Form Type	Document
Apr 29, 2024	4	Insider Trading
Apr 26, 2024	10-Q	Quarterly Report
Apr 26, 2024	8-K	Current Report
Apr 03, 2024	PX14A6G	PX14A6G
Apr 02, 2024	4	Insider Trading
Apr 02, 2024	4	Insider Trading
Apr 02, 2024	4	Insider Trading
Apr 02, 2024	4	Insider Trading
Apr 02, 2024	4	Insider Trading
Apr 02, 2024	4	Insider Trading

Peers (Alternatives to Centene Corp)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
UNH	462.0B	371.6B	9.96%	1.73%	20.64	1.24	14.64%	11.24%
CI	98.5B	206.0B	-4.33%	31.01%	25.56	0.48	12.55%	-43.95%
HCA	82.4B	66.7B	-4.37%	13.20%	15.06	1.23	9.59%	-4.59%
CVS	70.0B	360.9B	-25.27%	-20.02%	9.55	0.19	9.07%	78.49%
CNC	40.5B	155.5B	4.29%	11.16%	14.81	0.26	6.34%	84.42%
DVA	12.1B	12.3B	3.05%	54.33%	14.8	0.98	5.77%	58.74%
UHS	11.7B	14.3B	-2.27%	18.37%	16.37	0.82	6.59%	6.24%
MID-CAP
CHE	8.8B	2.3B	-7.98%	4.98%	30.96	3.83	5.96%	18.29%
ACHC	6.3B	3.0B	-11.24%	-2.13%	-553.66	2.09	10.92%	-104.06%
AMN	2.3B	3.8B	3.83%	-33.34%	10.82	0.6	-27.73%	-52.50%
AMEH	2.1B	1.4B	-9.08%	8.52%	34.65	1.52	21.19%	34.42%
SMALL-CAP
ADUS	1.7B	1.1B	2.42%	25.02%	26.07	1.57	11.45%	30.74%
BKD	1.4B	3.0B	8.71%	84.46%	-7.37	0.46	6.74%	20.73%
BEAT	54.0M	-	-2.35%	-2.35%	-3.69	-	-	-12.94%
AMS	19.6M	21.3M	10.24%	15.77%	36.7	0.92	8.00%	-62.25%

Centene Corp News

Latest updates

Centene Corp Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Income Statement (Quarterly)																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Revenue	2.4%	40,407	39,460	38,042	37,608	38,889	35,561	35,865	35,936	37,185	32,568	32,406	31,025	29,983	28,288	29,090	27,712	26,025	18,863	18,976	18,356	18,444
Costs and Expenses	-0.9%	39,301	39,654	37,307	36,437	37,671	35,843	35,389	36,065	35,932	31,965	31,861	31,443	28,929	28,273	28,229	25,694	25,837	18,586	18,800	17,713	17,759
S&GA Expenses	-7.7%	3,218	3,488	3,048	3,016	3,011	3,198	2,846	2,800	2,745	2,691	2,537	2,139	2,234	2,234	2,507	2,255	2,384	1,733	1,617	1,574	1,609
EBITDA Margin	-0.2%	0.04*	0.04*	0.04*	0.04*	0.03*	0.03*	0.03*	0.03*	0.03*	0.03*	0.02*	0.02*	0.05*	0.04*	-	-	-	-	-	-	-
Interest Expenses	-2.7%	178	183	181	181	180	174	169	162	160	162	170	163	170	177	184	187	180	113	99.00	101	99.00
Income Taxes	2200.0%	315	-15.00	293	360	261	260	269	-65.00	296	101	139	-7.00	244	-55.00	207	742	85.00	58.00	79.00	170	166
Earnings Before Taxes	6037.5%	1,473	24.00	768	1,415	1,391	41.00	1,009	-236	1,148	694	720	-542	941	-74.00	772	1,944	131	260	175	662	685
EBT Margin	1.3%	0.02*	0.02*	0.02*	0.03*	0.02*	0.01*	0.02*	0.02*	0.02*	0.01*	0.01*	0.01*	0.03*	0.02*	-	-	-	-	-	-	-
Net Income	2484.4%	1,163	45.00	469	1,058	1,130	-213	738	-172	849	599	584	-535	699	-12.00	568	1,206	46.00	209	95.00	495	522
Net Income Margin	0.2%	0.02*	0.02*	0.02*	0.02*	0.01*	0.01*	0.01*	0.01*	0.01*	0.01*	0.01*	0.01*	0.02*	0.02*	-	-	-	-	-	-	-
Free Cashflow	-10016.7%	-607	-6.00	885	2,331	4,044	-1,809	3,085	3,072	909	427	1,577	1,435	-144	2,775	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Assets	-2.4%	82,624	84,641	84,381	82,853	82,982	76,870	81,172	81,060	82,901	78,375	77,743	71,539	70,285	68,719	68,364	68,347	66,431	40,994	34,252	34,368	33,569
Current Assets	-5.7%	38,448	40,756	41,405	34,866	35,009	30,128	33,275	32,406	31,110	28,497	28,056	25,464	24,440	23,393	27,275	26,822	24,696	20,323	13,457	13,596	13,616
Cash Equivalents	2.3%	17,585	17,193	18,190	17,170	15,853	12,330	14,987	13,435	11,237	13,118	13,423	11,018	9,627	10,957	12,198	12,798	9,308	12,131	6,215	6,875	6,345
Net PPE	-1.5%	1,988	2,019	2,004	2,416	2,478	2,432	2,479	2,557	3,583	3,391	3,302	2,912	2,822	2,774	2,669	2,544	2,439	2,121	1,993	1,878	1,800
Goodwill	0%	17,558	17,558	17,558	18,716	18,836	18,812	20,040	20,310	20,903	19,771	19,699	18,805	18,788	18,652	17,964	17,434	17,417	6,863	6,872	7,126	6,981
Liabilities	-5.3%	55,560	58,685	58,965	57,066	57,796	52,633	55,572	54,497	55,471	51,353	51,069	45,411	43,749	42,757	42,485	43,142	42,739	28,302	21,816	22,098	21,925
Current Liabilities	-10.7%	32,784	36,716	36,851	31,306	32,857	28,464	31,330	29,086	29,685	25,765	25,042	23,642	22,279	21,585	21,795	21,918	21,651	12,932	13,280	12,653	13,143
Long Term Debt	1.0%	17,887	17,710	17,888	17,896	18,223	17,938	18,084	18,456	18,640	18,571	18,594	16,536	16,695	16,682	16,737	16,708	17,150	13,638	6,975	7,047	6,775
LT Debt, Current	-5.0%	113	119	113	110	97.00	82.00	249	300	292	267	245	253	62.00	97.00	89.00	106	129	88.00	66.00	87.00	40.00
LT Debt, Non Current	1.0%	17,887	17,710	17,888	17,896	18,223	17,938	18,084	18,456	18,640	18,571	18,594	16,536	16,695	16,682	16,737	16,708	17,150	13,638	6,975	7,047	6,775
Shareholder's Equity	4.3%	26,958	25,840	25,295	25,768	25,166	24,181	25,534	26,430	27,313	26,940	26,590	26,045	26,458	25,885	25,843	25,172	23,656	12,659	12,405	12,248	11,634
Retained Earnings	9.7%	13,206	12,043	11,998	11,529	10,471	9,341	9,554	8,816	8,988	8,139	7,540	6,956	7,491	6,792	6,804	6,236	5,030	4,984	4,775	4,680	4,185
Additional Paid-In Capital	0.4%	20,388	20,304	20,243	20,183	20,121	20,060	19,774	19,899	19,830	19,672	19,594	19,545	19,500	19,459	19,390	19,333	19,279	7,647	7,571	7,531	7,491
Shares Outstanding	0.4%	536	534	535	546	551	551	574	584	583	583	583	583	582	571	-	-	-	-	-	-	-
Minority Interest	-7.2%	90.00	97.00	100	97.00	124	124	156	141	144	145	124	134	116	112	118	116	107	108	94.00	94.00	94.00
Float	-	-	-	-	36,800	-	-	-	49,200	-	-	-	42,500	-	-	-	36,800	-	-	-	21,700	-

Cashflow (Last 12 Months)

(In Millions)

Cashflow (Quarterly)																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Cashflow From Operations	-310.1%	-456	217	1,021	2,546	4,269	-1,576	3,332	3,354	1,151	675	1,802	1,685	43.00	2,981	-952	3,714	-240	-651	-99.00	917	1,316
Share Based Compensation	42.9%	70.00	49.00	50.00	56.00	61.00	54.00	51.00	59.00	70.00	76.00	40.00	36.00	51.00	63.00	54.00	47.00	117	71.00	34.00	34.00	38.00
Cashflow From Investing	189.8%	852	-949	435	-424	-253	221	3.00	-744	-2,401	-857	-1,022	-813	-607	-4,255	332	240	-3,272	-144	-459	-556	-373
Cashflow From Financing	111.4%	23.00	-201	-524	-750	-183	-1,732	-1,481	-486	-498	-235	1,643	27.00	-73.00	-123	4.00	-460	839	6,704	-108	178	58.00
Buy Backs	387.1%	151	31.00	774	405	423	1,433	1,243	349	71.00	248	16.00	4.00	29.00	56.00	9.00	3.00	558	34.00	4.00	2.00	35.00

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

CNC Income Statement

2024-03-31

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Revenues:
Premium and service revenues	$ 36,337	$ 34,952
Premium tax	4,070	3,937
Total revenues	40,407	38,889
Expenses:
Medical costs	30,932	29,434
Cost of services	669	870
Selling, general and administrative expenses	3,218	3,011
Depreciation expense	135	142
Amortization of acquired intangible assets	173	183
Premium tax expense	4,161	4,011
Impairment	13	20
Total operating expenses	39,301	37,671
Earnings from operations	1,106	1,218
Other income (expense):
Investment and other income	545	353
Interest expense	(178)	(180)
Earnings before income tax	1,473	1,391
Income tax expense	315	261
Net earnings	1,158	1,130
Loss attributable to noncontrolling interests	5	0
Net earnings attributable to Centene Corporation	$ 1,163	$ 1,130
Net earnings per common share attributable to Centene Corporation:
Basic earnings per common share (in dollars per share)	$ 2.17	$ 2.05
Diluted earnings per common share (in dollars per share)	$ 2.16	$ 2.04
Weighted average number of common shares outstanding:
Basic (in shares)	535,109	550,779
Diluted (in shares)	538,060	553,845
Premium
Revenues:
Premium and service revenues	$ 35,529	$ 33,825
Service
Revenues:
Premium and service revenues	$ 808	$ 1,127

CNC Balance Sheet

2024-03-31

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023
Assets, Current [Abstract]
Cash and cash equivalents	$ 17,585	$ 17,193
Premium and trade receivables	16,824	15,532
Short-term investments	2,082	2,459
Other current assets	1,957	5,572
Total current assets	38,448	40,756
Long-term investments	16,496	16,286
Restricted deposits	1,383	1,386
Property, software and equipment, net	1,988	2,019
Goodwill	17,558	17,558
Intangible assets, net	5,928	6,101
Other long-term assets	823	535
Total assets	82,624	84,641
Current liabilities:
Medical claims liability	18,109	18,000
Accounts payable and accrued expenses	12,130	16,420
Return of premium payable	1,751	1,462
Unearned revenue	681	715
Current portion of long-term debt	113	119
Total current liabilities	32,784	36,716
Long-term debt	17,887	17,710
Deferred tax liability	734	641
Other long-term liabilities	4,155	3,618
Total liabilities	55,560	58,685
Commitments and contingencies
Redeemable noncontrolling interests	16	19
Stockholders' equity:
Preferred stock, $0.001 par value; authorized 10,000 shares; no shares issued or outstanding at March 31, 2024 and December 31, 2023	0	0
Common stock, $0.001 par value; authorized 800,000 shares; 619,173 issued and 536,383 outstanding at March 31, 2024, and 615,291 issued and 534,484 outstanding at December 31, 2023	1	1
Additional paid-in capital	20,388	20,304
Accumulated other comprehensive (loss)	(630)	(652)
Retained earnings	13,206	12,043
Treasury stock, at cost (82,790 and 80,807 shares, respectively)	(6,007)	(5,856)
Total Centene stockholders' equity	26,958	25,840
Nonredeemable noncontrolling interest	90	97
Total stockholders' equity	27,048	25,937
Total liabilities, redeemable noncontrolling interests and stockholders' equity	$ 82,624	$ 84,641

About Centene Corp

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. It operates in two segments, Managed Care and Specialty Services. The Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children's health insurance program, long-term services and support, foster care, and medicare-medicaid plans, which cover dually eligible individuals, as well as aged, blind, or disabled programs. This segment also provides a variety of individual, small group, and large group commercial healthcare products to employers and members. This segment also offers various individual, small group, and large group commercial healthcare products to employers and members. The Specialty Services segment offers behavioral health and employee assistance plans; clinical healthcare, primary care, various specialty services, and a suite of social and other support services; data analytics solutions; administrative services to Military Health System eligible beneficiaries; traditional pharmacy clinical and administrative services as well as specialized pharmacy benefit services through its specialty pharmacy business; and vision and dental health services. This segment provides auxiliary healthcare services and products to state programs, correctional facilities, healthcare organizations, employer groups, and other commercial organizations; and engages in the government contracts business under the TRICARE program and other healthcare related government contracts. The company provides its services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in St. Louis, Missouri.

CEO	Ms. Sarah M. London
WEBSITE	centene.com
INDUSTRY	Healthcare Plans
EMPLOYEES	65535

Centene Corp Frequently Asked Questions

What is the ticker symbol for Centene Corp? What does CNC stand for in stocks?

CNC is the stock ticker symbol of Centene Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Centene Corp (CNC)?

As of Tue May 07 2024, market cap of Centene Corp is 40.5 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of CNC stock?

You can check CNC's fair value in chart for subscribers.

What is the fair value of CNC stock?

You can check CNC's fair value in chart for subscribers. The fair value of Centene Corp is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Centene Corp is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for CNC so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Centene Corp a good stock to buy?

The fair value guage provides a quick view whether CNC is over valued or under valued. Whether Centene Corp is cheap or expensive depends on the assumptions which impact Centene Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for CNC.

What is Centene Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue May 07 2024, CNC's PE ratio (Price to Earnings) is 14.81 and Price to Sales (PS) ratio is 0.26. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. CNC PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Centene Corp's stock?

In the past 10 years, Centene Corp has provided 0.159 (multiply by 100 for percentage) rate of return.